Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.55+0.01 (+2.36%)
Close on Nov 17, 2026Market cap $50.92MP/E –Yield –
Citius Oncology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $1.49M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.67M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $3.94M | – |
See a number that looks wrong?